Trial Profile
A Single Center, Single-Dose, Open-Label, Randomized Study to Compare the Bioavailability of an Oral Test Formulation Containing Nitisinone 10 mg in at Least 16 Healthy Male and Female Subjects Under Fasting and Fed Conditions
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 31 Jul 2017
Price :
$35
*
At a glance
- Drugs Nitisinone (Primary)
- Indications Tyrosinaemia type I
- Focus Pharmacokinetics
- Sponsors Cycle Pharmaceuticals
- 31 Jul 2017 New trial record